ELAHERE
Analogs of ELAHERE
Find cheaper analogs and generic equivalents for ELAHERE.
Active Ingredient: MIRVETUXIMAB SORAVTANSINE
Product Overview
About ELAHERE
ELAHERE is a prescription medication containing the active ingredient mirvetuximab soravtansine, a monoclonal antibody-drug conjugate. It is used for the treatment of adult patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior chemotherapy regimens.
Key Benefits & Uses
- Treatment of platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
- Monotherapy for patients with a history of one to three prior chemotherapy regimens.
- Administered via intravenous infusion every 3 weeks.
Active Ingredient & Action
Mirvetuximab soravtansine works by binding to folate receptor-alpha (FRα), a protein overexpressed on the surface of certain cancer cells. The conjugate is then internalized and released, causing DNA damage and ultimately leading to cancer cell death.
Important Notes
ELAHERE is available only through a restricted distribution program called ELAHERE REMS. Patients must be enrolled in this program to receive the medication. It is essential to discuss the potential risks and benefits of ELAHERE with your healthcare provider before starting treatment.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.